智通财经APP获悉，三生制药(01530)涨超7%，截至发稿，涨6.85%，报17.63港元，成交额3.95亿港元。
消息面上，三生制药发布2026年中期业绩。上半年公司实现营业收入45.3亿元，同比增长3.9%；归母净利润11.5亿元，同比减少15.58%；经调整的经营性归母净利润14.4亿元，同比增长26.5%。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。集团预期于可预见未来人民币汇率波动对经营并无重大不利影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.